Pilot Study: Can Ultrasound Guided Biopsy be Used as an Alternative to Hysteroscopy?
1 other identifier
interventional
10
1 country
1
Brief Summary
Aim: Assess accuracy of histological diagnosis using ultrasound guided biopsy for women with suspected endometrial cancer (as an alternative to hysteroscopy guided biopsy). All women presenting to clinic with suspected endometrial cancer will have an internal ultrasound. If the endometrial lining is thickened an endometrial biopsy will be performed. This can sometimes be done in an outpatient clinic, or sometimes a hysteroscopy and biopsy is needed (on a different day). Hysteroscopy guided biopsy has the advantage of enabling the clinician to perform directed biopsies under vision. Ultrasound guided biopsy is a ubiquitous procedure when used elsewhere in the body however it is not routinely used in this context. It does have the advantage of being easily performed on the same day as the first consultation. In this pilot study the diagnostic ability and tolerability of ultrasound guided biopsy of women with suspected cancer will be assessed as an alternative to hysteroscopy guided biopsy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 13, 2017
CompletedFirst Submitted
Initial submission to the registry
June 30, 2017
CompletedFirst Posted
Study publicly available on registry
July 2, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2020
CompletedResults Posted
Study results publicly available
November 25, 2024
CompletedNovember 25, 2024
October 1, 2024
2.6 years
June 30, 2017
April 15, 2024
October 4, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Participants Whose Sample Was Successfully Analysed by Histological Diagnosis
All samples taken using ultrasound guided biopsy were analysed by histology lab. If they had sufficient tissue to give a diagnosis (benign, pre-malignant or malignant) this was deemed successful. It is deemed successful if there was sufficient tissue to give a histological analysis. So overall there will be a percentage success rate (number of tissue samples sufficient/number of tissue samples taken). Each patient would have had one sample.
1.5 years
Secondary Outcomes (1)
Patient Satisfaction of Ultrasound Guided Biopsy by Questionnaire
1.5 years
Study Arms (1)
Women needing endometrial biopsy
OTHERAll women who would be offered hysteroscopy guided biopsy as standard of care will be offered ultrasound guided biopsy first.
Interventions
For women needed a hysteroscopy guided biopsy as part of routine standard of care, women will now receive an ultrasound guided biopsy first
Eligibility Criteria
You may qualify if:
- All women presenting to rapid access gynaecology clinic with postmenopausal bleeding or intermenstrual bleeding or referred with a confirmed diagnosis of endometrial cancer.
You may not qualify if:
- Anyone lacking capacity. \<18years old. Pregnant.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Queen Charlotte and Hammersmith Hospital
London, W12 0HS, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Diana Marcus
- Organization
- Imperial College London
Study Officials
- PRINCIPAL INVESTIGATOR
Diana Marcus, MB BS
Imperial College London
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 30, 2017
First Posted
July 2, 2017
Study Start
June 13, 2017
Primary Completion
January 1, 2020
Study Completion
January 1, 2020
Last Updated
November 25, 2024
Results First Posted
November 25, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share
Will share results if published only.